Publication | Open Access

ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2–specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report

TransplantationHeartlung TransplantLong CovidCovid-19 PandemicImmunologyHeart Transplant PatientImmunotherapyMedicineCell TransplantationCovid-19Case Report